T. Le Chevalier

3.6k total citations · 1 hit paper
60 papers, 2.6k citations indexed

About

T. Le Chevalier is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, T. Le Chevalier has authored 60 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in T. Le Chevalier's work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (17 papers) and Lung Cancer Diagnosis and Treatment (10 papers). T. Le Chevalier is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (17 papers) and Lung Cancer Diagnosis and Treatment (10 papers). T. Le Chevalier collaborates with scholars based in France, United Kingdom and United States. T. Le Chevalier's co-authors include R. Arriagada, M. Spielmann, G Contesso, P Chomy, D Sarrazin, J.‐P. Lacour, F Fontaine, F. Rochard, Monique G. Lê and Michèle Tarayre and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

T. Le Chevalier

56 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer

1989 434 citations D Sarrazin, Monique G. Lê et al. Radiotherapy and Oncology profile →

Peers

Countries citing papers authored by T. Le Chevalier

Since Specialization

Citations

This map shows the geographic impact of T. Le Chevalier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Le Chevalier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Le Chevalier more than expected).

Fields of papers citing papers by T. Le Chevalier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Le Chevalier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Le Chevalier. The network helps show where T. Le Chevalier may publish in the future.

Co-authorship network of co-authors of T. Le Chevalier

This figure shows the co-authorship network connecting the top 25 collaborators of T. Le Chevalier. A scholar is included among the top collaborators of T. Le Chevalier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Le Chevalier. T. Le Chevalier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Experience of the Institut Gustave-Roussy in Alternating Radiotherapy and Chemotherapy Schedules as Induction Treatment in Limited Small-Cell Lung Cancer 2015 ·Antibiotics and chemotherapy/Antibiotica et chemotherapia ·T. Le Chevalier, R. Arriagada, François Thomas, P Baldeyrou, Pierre Ruffiè, Hubert de Crémoux, M. Martín, (unknown), (unknown), Michèle Tarayre, H Sancho-Garnier, A. Grop	0
2	Review of Toxicity and Long-Term Sequelae in Lung Cancer 2015 ·Antibiotics and chemotherapy/Antibiotica et chemotherapia ·T. Le Chevalier	0
3	Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials - NSCLC meta-analyses collaborative group 2008 ·Journal of Clinical Oncology ·Sarah Burdett, RJ Stephens, Lesley Stewart, Jayne F. Tierney, A. Aupérin, T. Le Chevalier, C. Le Péchoux, Jean‐Pierre Pignon, R. Arriagada, (unknown), D. Johnson, Jan P. van Meerbeeck, Max Parmar, R L Souhami, (unknown)	165
4	Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome 2004 ·Annals of Oncology ·Jean‐Philippe Spano, Fabrice André, Luc Morat, Laure Sabatier, Benjamin Besse, Christophe Combadière, Philippe Déterre, Alejandro Martı́n, J Azorin, Dominique Valeyre, D. Khayat, T. Le Chevalier, Jean‐Charles Soria	186
5	Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients 2003 ·Gene Therapy ·Frank Griscelli, Paule Opolon, Patrick Saulnier, Fathia Mami‐Chouaib, Erwan Gautier, Hamid Echchakir, Eric Angevin, T. Le Chevalier, Vincent Bataille, Patrick Squiban, Thomas Tursz, Bernard Escudier	29
6	Etoposide Plus Cisplatin With or Without the Combination of 4'-Epidoxorubicin Plus Cyclophosphamide in Treatment of Extensive Small-Cell Lung Cancer: a French Federation of Cancer Institutes Multicenter Phase III Randomized Study 2001 ·JNCI Journal of the National Cancer Institute ·Jean-Louis Pujol, Jean Pierre Daurès, Aart Brutel de la Rivière, Élisabeth Quoix, V. Westeel, Xavier Quantin, Jean-Luc Breton, É. Lemarié, M. Poudenx, B. Milleron, D. Del Moro, D. Debieuvre, T. Le Chevalier	111
7	Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO* analysis of prognostic factors 2001 ·British Journal of Cancer ·William Jacot, Xavier Quantin, Jean‐Marie Boher, Fabrice André, (unknown), (unknown), A Depierre, Élisabeth Quoix, T. Le Chevalier, J-L. Pujol	58
8	Management of cancer in pregnancy: A case of Ewing's sarcoma of the pelvis in the third trimester 1999 ·Annals of Oncology ·Ofer Merimsky, T. Le Chevalier, G. Missenard, C. Lepéchoux, Isabelle Cojean-Zelek, Benoı̂t Mesurolle, Axel Le Cesne	29
9	Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study. 1997 ·Journal of Clinical Oncology ·Jean-Louis Pujol, Jean‐Yves Douillard, Alain Rivière, Élisabeth Quoix, (unknown), P. Berthaud, (unknown), V. Polin, (unknown), B. Milleron, François Chomy, P Chomy, (unknown), T. Le Chevalier	56
10	Endobronchial brachytherapy (BT) with curative intent for small-sized bronchial carcinomas 1997 ·Lung Cancer ·P Baldeyrou, (unknown), H. Marsiglia, (unknown), Éric Lartigau, Barbara Frederick, (unknown), (unknown), (unknown), Claire Petit, R. Arriagada, T. Le Chevalier, Sylvie Guérin, A. Gerbaulet	1
11	Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products. 1997 ·Journal of Clinical Investigation ·Hanne Gahéry‐Ségard, Valérie Molinier‐Frenkel, (unknown), Patrick Saulnier, Paule Opolon, Renée Lengagne, Erwan Gautier, Axel Le Cesne, Laurence Zitvogel, A Venet, C. Schatz, Michael Courtney, T. Le Chevalier, Thomas Tursz, J G Guillet, Françoise Farace	97
12	Ca125 and neuron-specific enolase (NSE) as tumour markers for intra-abdominal desmoplastic small round-cell tumours 1997 ·British Journal of Cancer ·Karim Fizazi, Fadi Farhat, Christine Théodore, Olivier Rixe, Axel Le Cesne, E Comoy, T. Le Chevalier	23
13	Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. 1996 ·Journal of Clinical Oncology ·(unknown), Michel Ducreux, P Baldeyrou, P Rougier, T. Le Chevalier, J Bougaran, P Lasser, Brice Gayet, Pierre Ruffiè, Dominique Grunenwald	155
14	Restoration of functional gait in paraplegic patients with the RGO-II hybrid orthosis. A multicenter controlled study. II: Physiological evaluation 1995 ·Spinal Cord ·P. Thoumie, (unknown), J. Beillot, J Dassonville, T. Le Chevalier, B. Perrouin-Verbe, (unknown), (unknown), (unknown), (unknown), J.-F. Mathé, F. Moutet, (unknown), (unknown)	63
15	Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete Remission 1995 ·JNCI Journal of the National Cancer Institute ·R. Arriagada, T. Le Chevalier, (unknown), Antoine Rivière, P Chomy, Isabelle Monnet, A. Tardivon, Fausto Viader, Michèle Tarayre, Simone Benhamou	392
16	Surgical Resection of Pulmonary Metastases. Up to What Number? 1994 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), P Baldeyrou, T. Le Chevalier, (unknown), (unknown), M. Spielmann, Dominique Grunenwald	46
17	Phase II study of elliptinium acetate salvage treatment of advanced breast cancer 1993 ·European Journal of Cancer ·Jacques Rouëssé, M. Spielmann, F Turpin, T. Le Chevalier, Mohamed Azab, (unknown)	43
18	Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer breakdown → 1989 ·Radiotherapy and Oncology ·D Sarrazin, Monique G. Lê, R. Arriagada, G Contesso, F Fontaine, M. Spielmann, F. Rochard, T. Le Chevalier, J.‐P. Lacour	434
19	The role of CT in the pulmonary evaluation of osteosarcomas: A study of 21 cases checked histologically 1987 ·D. Vanel, (unknown), C Kalifa, (unknown), T. Le Chevalier, G Contesso, D. Couanet, Philipp Kron	1
20	Chimiothérapie première dans les sarcomes des parties molles considérés comme inopérables. 1983 ·Jacques Rouëssé, T. Le Chevalier, G Contesso, D Sarrazin, Jeanne Amiel, (unknown), Patrice Carde, J Génin	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact